French firm scales up HDL cholesterol drug tests By: Reuters: Company News March 14, 2011 at 19:01 PM EDT * Cerenis Phase II drug study aims to show plaque removal Read More >> Related Stocks: 1-3 Year Credit Bond Ishares ETF Carlisle Companies Inc Merck & Co Rogers Corp